Phase 4, also known as post-marketing surveillance, refers to the stage of clinical trials that occurs after a drug or treatment has received approval from regulatory authorities for public use. During this phase, the safety and efficacy of the treatment are monitored in a larger population, allowing for the identification of any rare or long-term side effects that may not have been evident in earlier trials.
congrats on reading the definition of Phase 4. now let's actually learn it.